More articles on this subject
When Breast Cancer Comes Back: When breast cancer comes back, it can take many forms, which determines treatment, outcome, and prognosis ...
webmd.com/breast-cancer/breast-cancer-comes-back
When Breast Cancer Comes Back
Similar to This
Understanding breast cancer recurrence: Risks, types, and management: Understanding breast cancer recurrence: Risks, types, and management
nation.africa/kenya/health/understanding-breast-cancer-recurrence-risks-types-and-management-5641530
Understanding breast cancer recurrence: Risks, types, and management
Roche Bets on Breast Cancer Pill to Prevent Tumor Recurrence: The Swiss firm has lost its lead in the booming oncology treatment market. It’s betting on ...
bloomberg.com/news/features/2026-10-20/roche-bets-on-cancer-pill-to-prevent-breast-tumor-recurrence
Roche Bets on Breast Cancer Pill to Prevent Tumor Recurrence
Why breast cancer can return after treatment: The Uganda Cancer Institute (UCI), located in Mulago, Kampala, provides cancer screening, diagnosis ...
monitor.co.ug/uganda/magazines/healthy-living/why-breast-cancer-can-return-after-treatment-5634956
Why breast cancer can return after treatment
Two men were gunned down in separate shootings in New Providence last night, according to police.
'If you prosecute one, you have to prosecute all': A former member of the Water and Sewerage Corporation board insisted that prosecutions should be applied ...
thenassauguardian.com/_services/v1/client_captcha/challenge
'If you prosecute one, you have to prosecute all'
Breast Cancer Can Return After Treatment—New Blood Test May Spot It Earlier: Recurrence is currently generally diagnosed by mammogram, ultrasound, biopsies ...
newsweek.com/breast-cancer-can-return-after-treatment-new-blood-test-may-spot-it-earlier-12362301
Breast Cancer Can Return After Treatment—New Blood Test May Spot It ...
What COVID is teaching doctors about the relationship between viruses and cancer: "We think that these virus infections can be almost like fuel for the fire ...
pressdemocrat.com/2026/07/03/covid-doctors-viruses-cancer/
What COVID is teaching doctors about the relationship between viruses and ...
Breast cancer tumor vaccine being studied at Stony Brook Medicine: Stony Brook Cancer Center is one of 160 sites worldwide participating in the FLAMINGO-01 Phase ...
newsday.com/news/health/breast-cancer-tumor-vaccine-s5vycefh
Breast cancer tumor vaccine being studied at Stony Brook Medicine
What To Know About Breast Cancer Recurrence : Recurrence is when cancer returns months or years later. Early-stage breast cancer often responds well to treatment ...
health.clevelandclinic.org/early-breast-cancer-recurrence-risk
What To Know About Breast Cancer Recurrence
SABCS: The Drug Giredestrant Reduces the Risk of Recurrence of Dangerous Breast Cancer | NEWS.am Medicine - All about health and medicine
med.news.am/eng/news/40123/sabcs-the-drug-giredestrant-reduces-the-risk-of-recurrence-of-dangerous-breast-cancer.html
SABCS: The Drug Giredestrant Reduces the Risk of Recurrence of Dangerous ...
Massive cancer find on med used by millions: A cheap medicine already on the market and used by millions of people may be able to stop a type of aggressive ...
news.com.au/lifestyle/health/health-problems/triplenegative-breast-cancer-may-be-stopped-by-beta-blockers-according-to-new-research/news-story/8d4f43e777013c433e4dd83a492a29d1
Massive cancer find on med used by millions
New study finds triple-negative breast cancer tumors with an increase in immune cells have lower risk of recurrence after surgery
newsnetwork.mayoclinic.org/discussion/new-study-finds-triple-negative-breast-cancer-tumors-with-an-increase-in-immune-cells-have-lower-risk-of-recurrence-after-surgery/
New study finds triple-negative breast cancer tumors with an increase in ...
Key FactsImmune Cells Reduce Recurrence Risk in Breast Cancer
Apr 2, 2024 · Reading time: ~45 sec.
Summary created with AI assistance · Source: newsnetwork.mayoclinic.org
  • Early-stage triple-negative breast cancer patients with elevated tumor-infiltrating lymphocytes (TILs) show lower recurrence rates without chemotherapy.

  • Nearly 2,000 participants were followed for a median of 18 years in this international study.

  • TIL presence may become a standard prognostic biomarker to guide treatment decisions in TNBC.

  • Detecting immune cells visually under a microscope adds no extra cost, aiding use in low-resource settings.
  • This is an important finding because it highlights that the abundance of TILs in breast tissue is a prognostic biomarker in people with early-stage triple-negative breast cancer, even when chemotherapy is not administered.
    — Roberto Leon-Ferre, M.D., a breast medical oncologist at Mayo Clinic Comprehensive Cancer Center and first author of the study.